Skip to main content
Clinical Trials/NCT05775757
NCT05775757
Recruiting
Not Applicable

Registry for Analysis of Impact of Radiation Dose to Skin on Cosmetic Outcome and Patient-reported Outcomes in Patients With Breast Cancer Treated With Radiation Therapy

Samsung Medical Center1 site in 1 country500 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Radiotherapy Side Effect
Sponsor
Samsung Medical Center
Enrollment
500
Locations
1
Primary Endpoint
Change of cosmesis from baseline
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy.

The main question it aims to answer are:

  • Changes in breast skin
  • Factors related to breast skin changes
  • Patient-reported outcomes
  • Cosmetic outcomes

Participants will be assessed by multi-dimensional methods before and after radiotherapy:

  • Photographs
  • Fibrometer
  • Questionnaires (BREAST-Q)
  • CTCAE version 4.03 evaluated by treating physicians
Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2030
Last Updated
10 months ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Haeyoung Kim

Associate professor

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • Breast cancer treated with curative surgery

Exclusion Criteria

  • History of thoracic radiation therapy

Outcomes

Primary Outcomes

Change of cosmesis from baseline

Time Frame: 5 year after radiation therapy

Evaluated by two blinded independent physicians based on photographs

Change of patient-reported outcome from baseline

Time Frame: 5 year after radiation therapy

BREAST-Q questionnaire is used to evaluate patient-reported outcome.

Change of fibrosis from baseline

Time Frame: 5 year after radiation therapy

Evaluated using fibrometer measuring both breast

Physician assessed toxicity

Time Frame: 5 year after radiation therapy

CTCAE version 4.03 is used to evaluate physician-assessed toxicities.

Study Sites (1)

Loading locations...

Similar Trials